Asian Paints:2,660.70+28.43 (+1.08%)
Cipla:1,379.30-10.98 (-0.79%)
Eicher Motors:7,141.50+41.18 (+0.58%)
Nestle India:1,398.70+6.96 (+0.50%)
Grasim Inds:3,097.60-4.96 (-0.16%)
Hindalco Inds.:1,146.30+5.02 (+0.44%)
Hind. Unilever:2,093.70+9.38 (+0.45%)
ITC:283.25+3.61 (+1.29%)
Trent:4,210.40+53.21 (+1.28%)
Larsen & Toubro:4,000.90-10.03 (-0.25%)
M & M:2,998.30+28.22 (+0.95%)
Reliance Industries:1,314.60-5.41 (-0.41%)
Tata Consumer:1,154.70+11.43 (+1.00%)
Tata Motors PVeh:390.20+5.31 (+1.38%)
Tata Steel:210.60+0.02 (+0.01%)
Wipro:209.84+3.43 (+1.66%)
Apollo Hospitals:8,089.50-18.65 (-0.23%)
Dr Reddy's Labs:1,274.00-16.39 (-1.27%)
Titan Company:4,078.10+53.53 (+1.33%)
SBI:956.65+2.58 (+0.27%)
Shriram Finance:911.70-7.35 (-0.80%)
Bharat Electron:407.85+0.65 (+0.16%)
Kotak Mah. Bank:379.05+1.66 (+0.44%)
Infosys:1,270.80+68.30 (+5.68%)
Bajaj Finance:882.00-7.02 (-0.79%)
Adani Enterp.:2,968.10+58.77 (+2.02%)
Sun Pharma.Inds.:1,789.90-6.65 (-0.37%)
JSW Steel:1,310.80+11.43 (+0.88%)
HDFC Bank:748.25+5.57 (+0.75%)
TCS:2,446.90+149.56 (+6.51%)
ICICI Bank:1,226.60-13.14 (-1.06%)
Power Grid Corpn:282.15-4.01 (-1.40%)
Maruti Suzuki:13,022.00+76.38 (+0.59%)
Axis Bank:1,251.10-24.75 (-1.94%)
HCL Technologies:1,243.50+48.40 (+4.05%)
O N G C:265.05+0.74 (+0.28%)
NTPC:367.40-11.28 (-2.98%)
Coal India:472.15-0.47 (-0.10%)
Bharti Airtel:1,814.20+3.62 (+0.20%)
Tech Mahindra:1,571.40+28.24 (+1.83%)
Jio Financial:237.64+2.68 (+1.14%)
Adani Ports:1,814.50+31.03 (+1.74%)
HDFC Life Insur.:579.90-6.63 (-1.13%)
SBI Life Insuran:1,801.70-10.88 (-0.60%)
Max Healthcare:948.70+10.23 (+1.09%)
UltraTech Cem.:11,165.00-67.39 (-0.60%)
Bajaj Auto:10,281.00-95.46 (-0.92%)
Bajaj Finserv:1,741.40-17.41 (-0.99%)
Interglobe Aviat:4,466.10+12.91 (+0.29%)
Eternal:250.75+2.65 (+1.07%)
Asian Paints:2,660.70+28.43 (+1.08%)
Cipla:1,379.30-10.98 (-0.79%)
Eicher Motors:7,141.50+41.18 (+0.58%)
Nestle India:1,398.70+6.96 (+0.50%)
Grasim Inds:3,097.60-4.96 (-0.16%)
Hindalco Inds.:1,146.30+5.02 (+0.44%)
Hind. Unilever:2,093.70+9.38 (+0.45%)
ITC:283.25+3.61 (+1.29%)
Trent:4,210.40+53.21 (+1.28%)
Larsen & Toubro:4,000.90-10.03 (-0.25%)
M & M:2,998.30+28.22 (+0.95%)
Reliance Industries:1,314.60-5.41 (-0.41%)
Tata Consumer:1,154.70+11.43 (+1.00%)
Tata Motors PVeh:390.20+5.31 (+1.38%)
Tata Steel:210.60+0.02 (+0.01%)
Wipro:209.84+3.43 (+1.66%)
Apollo Hospitals:8,089.50-18.65 (-0.23%)
Dr Reddy's Labs:1,274.00-16.39 (-1.27%)
Titan Company:4,078.10+53.53 (+1.33%)
SBI:956.65+2.58 (+0.27%)
Shriram Finance:911.70-7.35 (-0.80%)
Bharat Electron:407.85+0.65 (+0.16%)
Kotak Mah. Bank:379.05+1.66 (+0.44%)
Infosys:1,270.80+68.30 (+5.68%)
Bajaj Finance:882.00-7.02 (-0.79%)
Adani Enterp.:2,968.10+58.77 (+2.02%)
Sun Pharma.Inds.:1,789.90-6.65 (-0.37%)
JSW Steel:1,310.80+11.43 (+0.88%)
HDFC Bank:748.25+5.57 (+0.75%)
TCS:2,446.90+149.56 (+6.51%)
ICICI Bank:1,226.60-13.14 (-1.06%)
Power Grid Corpn:282.15-4.01 (-1.40%)
Maruti Suzuki:13,022.00+76.38 (+0.59%)
Axis Bank:1,251.10-24.75 (-1.94%)
HCL Technologies:1,243.50+48.40 (+4.05%)
O N G C:265.05+0.74 (+0.28%)
NTPC:367.40-11.28 (-2.98%)
Coal India:472.15-0.47 (-0.10%)
Bharti Airtel:1,814.20+3.62 (+0.20%)
Tech Mahindra:1,571.40+28.24 (+1.83%)
Jio Financial:237.64+2.68 (+1.14%)
Adani Ports:1,814.50+31.03 (+1.74%)
HDFC Life Insur.:579.90-6.63 (-1.13%)
SBI Life Insuran:1,801.70-10.88 (-0.60%)
Max Healthcare:948.70+10.23 (+1.09%)
UltraTech Cem.:11,165.00-67.39 (-0.60%)
Bajaj Auto:10,281.00-95.46 (-0.92%)
Bajaj Finserv:1,741.40-17.41 (-0.99%)
Interglobe Aviat:4,466.10+12.91 (+0.29%)
Eternal:250.75+2.65 (+1.07%)

Arihant Plus App

Emcure Pharmaceuticals Ltd

Emcure Pharma | 544210

Market Closed
1,704.40
0.85 (-0.05%)
As on 03/06/26, 12:13 AM
Market Cap32,328.81 CR
Current Price₹1,704.4
High / Low₹1,830 / 1,228.9
PE Ratio29.83
Book Value₹234.65
Dividend Yield0.28%
ROCE20.01%
ROE12.79%
Face Value₹2.00
Current Vol.1,41,150
Average Vol.---
ISININE168P01015
PB Ratio4.57
Debt to Equity0.45
Net Profit Margin8.96
Operating Margin19.39

Stock Charts

📊

No Information Available

Stock charts information is not available at this time.

Stock Performance

2,4802,490
2,500
Previous CloseToday's Open
1,8003,000
2,500
52W Low52W High
₹2,480Today's Open
₹2,490Previous Close
12,00,000Volume
₹1,80052W Low
₹3,00052W High

Ratios

No data available

About Company

  • Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited', as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Registrar of Companies, Maharashtra at Bombay
  • Subsequently, Company was converted into a Public Company and the name of Company was changed to Emcure Pharmaceuticals Limited', through a fresh Certificate of Incorporation issued by the RoC, Maharashtra in Pune on September 18, 2001
  • Emcure Pharmaceuticals an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a broad
  • range of pharmaceutical products across several major therapeutic areas
  • In India, they are present across acute and chronic therapeutic areas, and their key therapeutic areas include gynecology, cardiovascular, vitamins, minerals and nutrients, human immunodeficiency virus antivirals, blood-related and oncology/anti-neoplastics
  • The Company has 13 manufacturing facilities across India
  • It keeps a strong track record in developing portfolios of differentiated products, including chiral molecules, complex APIs, biologics and novel drug delivery systems
  • It has a portfolio of 11 chiral molecules, of which 6 have been launched so far
  • In year 1999, Lasor Drugs Limited was amalgamated with the Company
  • Thereafter, Emcure Laboratories Private Limited

Ethics: Emcure Pharmaceuticals Ltd is flagged for

paw image

Animal Cruelty

The company engages directly in some form of animal cruelty through its business.

Research Calls

Research Calls
Locked Access

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI53.27
SMA 201699.13
SMA 501632.03
SMA 1001561.37
SMA 2001471.90
SMA 101715.88
MACD_12_26_Days23.18
EMA10Day1708.03
EMA20Day1693.42
EMA50Day1639.97
MACD_12_26_9_Days-4.22
EMA100Day1572.80
EMA200Day1496.92

Pivot Points

Volume Analysis

Delivery
Total Volume

Growth Rate

Revenue Growth18.59%
ROE19.12%
EBITDA Margin19.39%

All figures in ₹ Crores

Indicators20252024202320222021
Revenue
7,896.00
6,658.25
5,985.81
5,855.39
5,033.47
Interest
175.78
237.15
213.61
175.98
154.94
Expenses
6,427.14
5,428.53
4,804.63
4,525.48
3,817.19
Financing Profit
1,541.64
1,286.71
1,227.09
1,393.38
1,250.16
Financing Margin %
20%
19%
20%
24%
25%
Other Income
72.79
56.99
45.91
63.47
33.88
Depreciation
384.13
312.41
260.12
244.86
249.99
Profit before tax
971.35
727.23
747.22
972.55
840.70
Tax %
27%
27%
25%
28%
28%
Net Profit
707.47
527.57
561.85
702.56
607.25
EPS in Rs
36.43
27.54
29.42
36.62
21.68
Show % Change
ShareHolding
📊

No Information Available

No shareholding data available at this time.

DealDateTypeQuantityPriceTraded %
NORGES BANK ON ACCOUNT OF THE GOVERNMENT PENSION FUND GLOBAL29 Apr ‘26Purchase18,00,0001,608.2126.34%
BC INVESTMENTS IV LIMITED29 Apr ‘26Sell18,00,0001,608.2126.34%

News

📊

No Information Available

No news available for this company.
Record Date
Corporate Action
Information
Announcement Day
28 Aug 2025
AGM
AGM
01 Aug 2025
14 Aug 2025
Final Dividend (₹3)
Board of Directors of the Company at its meeting held today i.e. Thursday, May 22, 2025, has inter-alia transacted and approved/ recommended the following businesses: Recommended a final dividend of Rs. 3 / - (Rupees Three only) per equity share of Rs. 10 /- (Rupees Ten only) each of the Company (at the rate of 30%) for the financial year ended March 31, 2025, subject to approval of the Members of the Company at the ensuing Annual General Meeting of the Company. Dividend, once approved by the Members, shall be paid within the prescribed timeline under the Companies Act, 2013. Intimation of the 44th AGM and Record date for Final Dividend for the financial year ended March 31, 2025. (As Per BSE Announcement Dated on: 01/08/2025)
22 May 2025

Peers

LTP(₹)
Market Cap(₹ Cr.)
P/E Ratio(Ratio)
P/B Ratio(Ratio)
Cash Earnings(Ratio)
Debt to Equity(Ratio)
Net Profit Ratio(%)
1,698
32,196
34
7
24
0
8.96%
1,790
4,29,469
34
5
28
0
20.88%
6,528
1,73,305
66
10
56
0
23.41%
4,314
1,46,014
66
17
44
1
16.60%
1,379
1,11,388
27
3
21
0
19.21%
1,077
1,08,397
20
4
16
0
19.86%
1,275
1,06,381
25
3
17
0
17.54%
2,250
1,02,853
18
5
14
0
14.56%
2,299
94,907
47
6
33
0
14.39%
1,429
83,017
23
2
16
0
10.98%
Showing 10 of 133 Results

Frequently Asked Questions

What is Share Price of Emcure Pharmaceuticals Ltd?

The current share price of Emcure Pharmaceuticals Ltd (Emcure Pharma) is ₹1704.40. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Emcure Pharmaceuticals Ltd?

The Price-to-Earnings (P/E) ratio of Emcure Pharmaceuticals Ltd is 1704.40. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Emcure Pharmaceuticals Ltd?

Emcure Pharmaceuticals Ltd has a 52-week high of ₹1830.00 and a 52-week low of ₹1228.90. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Emcure Pharmaceuticals Ltd?

Emcure Pharmaceuticals Ltd offers a dividend yield of 0.18%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Emcure Pharmaceuticals Ltd?

The Earnings Per Share (EPS) of Emcure Pharmaceuticals Ltd is ₹49.91. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Emcure Pharmaceuticals Ltd?

Emcure Pharmaceuticals Ltd has a Return on Equity (ROE) of 12.79%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

mobile

Ready to invest smarter?
Download the app today.

app store

GET IT ON

Google Play

4.5

app store

DOWNLOAD ON THE

App Store

4.2